Imidazole and carbazole derivatives as potential anticancer agents: molecular docking studies and cytotoxic activity evaluation

Abstract

Carbazoles and imidazole represent two important classes of heterocycles which exhibit diverse biological activities such as antitumor properties. In this study, imidazole (C1-C3) and carbazole (C4 and C5) derivatives were evaluated for their cytotoxic activity against three human cancer cell lines namely, MCF7 (human breast cancer), HT29 (human colon cancer), and HeLa (human cervical cancer). Carbazole derivatives (C4 and C5) with IC50 < 10 µM showed greater cytotoxic effect than imidazole derivatives (C1-C3). Furthermore, all compounds exhibited better anticancer activity against MCF-7 than other two cell lines (HT-29, HeLa) and compound C4 was the most potent compound with the IC50 values of 2.5, 5.4 and 4.0 µM, against MCF-7, Hela and HT-29 cell lines, respectively. Physicochemical properties of compounds were calculated and their correlation with the IC50 values on MCF-7 cell line investigated. Surface area and polarizability of compounds showed good correlation by R2 = 0.8396 and R2 = 0.834, respectively. Docking studies of these compounds were also performed on the DNA as proposed target to comprehend their binding interactions and binding energies. The docking energy of compounds ranged from - 11.32 to -13.48 kcal/mol. Compound C3 with energy of -13.48 kcal/mol had the highest docking energy. Docking results indicated that these compounds (C1-C5) had strong affinity in binding to the DNA.
 
 KEY WORDS: Imidazole, Carbazole, Molecular docking, Cancer, MTT assay
 
 Bull. Chem. Soc. Ethiop. 2020, 34(2), 377-384
 DOI: https://dx.doi.org/10.4314/bcse.v34i2.14

Novel Hydrazone Derivatives of 3‐Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies

“…The three‐dimensional crystal structure of the HK II (PDB ID: 2NTZ) enzyme was obtained from the protein data bank (http://www.rcsb.org/pdb). After removing water molecules and co‐crystal ligand (3‐BP), the enzyme was converted to PDBQT, and gasteiger partial charges were added using MGLTools 1.5.6 [44,45] . The structure of each ligand was drawn by the ChemBioDraw (version 12.0) and optimized using Hyperchem (Version 8, Hypercube Inc., Gainesville, FL, USA) software.…”

“…After removing water molecules and co-crystal ligand (3-BP), the enzyme was converted to PDBQT, and gasteiger partial charges were added using MGLTools 1.5.6. [44,45] The structure of each ligand was drawn by the ChemBioDraw (version 12.0) and optimized using Hyperchem (Version 8, Hypercube Inc., Gainesville, FL, USA) software. During the optimization procedure, the molecular mechanics (MM +) method and then the quantumbased semiempirical method (AM1) were utilized.…”

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective

“…Compound 51 showed the most potent activity at IC 50 values of 2.5, 5.36 and 4.03 µM, respectively. Doxorubicin was used as positive control with the IC 50 values 1.4 µM, 0.7 µM, and 0.9 µM respectively [ 168 ]. Oskuei et al (2021) synthesized new imidazole chalcone derivatives and performed MTT assays against four cancer cell lines, including A549, MCF-7, HEPG2 and MCF-7/MX.…”

ROS‐Mediated Antitumor Activity, Apoptosis, and Molecular Docking Studies of Platinum(II) Coordination Complexes Bearing 2‐(Diphenylphosphino)pyridine Ligands

“…The cytotoxic activity of Pt(II) complexes containing dppy ligand 1 a, 1 b, and 1 c was evaluated against ovarian (SKOV3), lung (A549), and breast (MCF7) cancer cell lines using MTT assay. [32,33] The % inhibition of complexes against cancer cell lines was calculated at concentrations of 1.25 μM, 2.5 μM, 5 μM, 10 μM, 50 μM, and 100 μM (Figure S1). The best cytotoxic activity and the highest % inhibition against the studied cancer cells were observed for complexes 1 b.…”